PUVA therapy for palmoplantar pustulosis.

Area of Science:

• Dermatology
• Phototherapy

Background:

• Pustulosis palmoplantaris is a chronic skin condition affecting the palms and soles.
• Effective treatment options are needed to manage this debilitating condition.

Purpose of the Study:

• To evaluate the efficacy and long-term outcomes of Psoralen plus ultraviolet A (PUVA) therapy for pustulosis palmoplantaris.
• To assess treatment response for both palmar and plantar lesions.

Main Methods:

• Forty patients with pustulosis palmoplantaris received PUVA therapy.
• Treatment involved sessions of UVA light exposure, with varying frequencies and durations.
• Dosage and patient response were monitored throughout the study.

Main Results:

• Significant clearance of palmar lesions was achieved in 31 out of 36 patients.
• Remission rates for palmar lesions were sustained in 9 cases after 2 years, with an average remission duration of over 15 months.
• Plantar lesion treatment yielded lower success rates, with healing in only 5 out of 34 cases.
• Nausea was a frequently reported side effect.

Conclusions:

• PUVA therapy demonstrates considerable efficacy in treating palmar pustulosis palmoplantaris, offering long-term remission.
• Treatment outcomes for plantar lesions are less favorable compared to palmar lesions.
• While generally beneficial, potential side effects like nausea should be considered during PUVA therapy.